News Related to AAV vector

Related coverage linked through entity extraction aliases.

First AAV gene therapy trial for type 1 diabetes to begin this year

Apr 23, 2026

The first clinical trial of an AAV gene therapy for type 1 diabetes is set to begin this year. The 52-week phase 1 PROGRESS study will test one-time intramuscular KRIYA-839 in adults with A1c above 7% using automated insulin delivery systems.

FDA Places Clinical Holds on Regenxbio Gene Therapies for Rare Metabolic Disorders

Jan 29, 2026

The FDA placed clinical holds on Regenxbio's RGX-111 and RGX-121 gene therapies following a tumor case in an MPS I patient. The company's stock fell nearly 18% on the news.